Results 131 to 140 of about 13,957 (152)

Abbreviated Magnetic Resonance Imaging With Breath‐Hold Three‐Dimensional Magnetic Resonance Cholangiopancreatography: Assessment of Malignant Risk of Pancreatic Intraductal Papillary Mucinous Neoplasm

Journal of Magnetic Resonance Imaging, 2021
For surveillance of pancreatic intraductal papillary mucinous neoplasms (IPMNs), magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) is preferred over computed tomography, but the long acquisition time limits its use.
Jeongin Yoo, J. Min, D. H. Lee, B. Hur, Se Woo Kim, EunJu Kim   +5 more
semanticscholar   +1 more source

Histopathological evaluation of minor salivary gland papillary–cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm

Histopathology, 2020
Minor salivary gland tumours showing a predominant papillary–cystic structure are rare, and constitute a mixture of various types of neoplasm; thus, the histopathological assessment of these tumours poses a significant diagnostic challenge.
Masato Nakaguro, M. Urano, I. Ogawa, H. Hirai, Yoshinari Yamamoto, H. Yamaguchi, Maki Tanigawa, J. Matsubayashi, H. Hirano, J. Shibahara, Y. Tada, T. Tsuzuki, Y. Okada, Yuichiro Sato, K. Ikeda, Aoi Sukeda, Y. Honda, Y. Mikami, T. Nagao   +18 more
semanticscholar   +1 more source

Natural history and optimal treatment strategy of intraductal papillary mucinous neoplasm of the pancreas: Analysis using a nomogram and Markov decision model

Journal of hepato-biliary-pancreatic sciences, 2020
With the increase in detection of intraductal papillary mucinous neoplasms (IPMN), a tailored approach is needed. This study was aimed at exploring the natural history of IPMN and suggest optimal treatment based on malignancy risk using a nomogram and ...
Youngmin Han, Jin‐Young Jang, M. Y. Oh, H. Kim, Y. Byun, J. Kang, S. H. Kim, K. Lee, Hongbeom Kim, W. Kwon   +9 more
semanticscholar   +1 more source

Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.

Gastroenterology, 2017
BACKGROUND & AIMS Little is known about the development of branch duct intraductal papillary mucinous neoplasms (BD-IPMNs). We evaluated long-term outcomes of a large cohort of patients with BD-IPMNs to determine risk of malignancy and define a subset of
I. Pergolini, K. Sahora, C. Ferrone, V. Morales-Oyarvide, B. Wolpin, L. Mucci, W. Brugge, M. Mino‐Kenudson, M. Patiňo, D. Sahani, A. Warshaw, K. Lillemoe, C. F. Fernandez-Del Castillo   +12 more
semanticscholar   +1 more source

Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines.

Radiology, 2019
Background Several changes have been made to the revised 2017 international consensus guidelines for management of pancreatic intraductal papillary mucinous neoplasms (IPMNs). However, the diagnostic performance is yet to be verified. Purpose To evaluate
J. E. Lee, Seo-Youn Choi, J. Min, B. Yi, Min Hee Lee, Seung Soo Kim, Jeong Ah Hwang, J. H. Kim   +7 more
semanticscholar   +1 more source

Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma

Pancreas, 2018
For early detection of pancreatic cancer, interests are now focused on the detection of high-risk individuals to undergo screening examinations. Intraductal papillary mucinous neoplasm (IPMN) is a unique dual precursor of pancreatic cancer, characterized
Masao Tanaka
semanticscholar   +1 more source

New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm.

Annals of Surgery, 2018
OBJECTIVE To create a simple, objective model to predict the presence of malignancy in patients with intraductal papillary mucinous neoplasm (IPMN), which can be easily applied in daily practice and, importantly, adopted for any lesion types ...
Y. Shimizu, S. Hijioka, S. Hirono, T. Kin, T. Ohtsuka, A. Kanno, Shinsuke Koshita, K. Hanada, M. Kitano, H. Inoue, T. Itoi, T. Ueki, K. Matsuo, A. Yanagisawa, H. Yamaue, M. Sugiyama, K. Okazaki   +16 more
semanticscholar   +1 more source

Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm

Annals of Surgery, 2016
Objective:To identify factors predicting the development of high-risk lesions in the remnant pancreas after surgery for intraductal papillary mucinous neoplasm (IPMN).
Y. Miyasaka, T. Ohtsuka, K. Tamura, Yasuhisa Mori, Koji Shindo, D. Yamada, S. Takahata, K. Ishigami, Tetsuhide Ito, S. Tokunaga, Y. Oda, K. Mizumoto, Masafumi Nakamura, Masao Tanaka   +13 more
semanticscholar   +1 more source

Intraductal papillary mucinous neoplasm of the pancreas – epidemiology, risk factors, diagnosis, and management

Scandinavian Journal of Gastroenterology, 2017
Intraductal papillary mucinous neoplasm (IPMN) is one of the most common cystic neoplasms of the pancreas. It is a heterogeneous disease and can be divided into ductal types and morphological subtypes.
Linus Aronsson, R. Andersson, D. Ansari
semanticscholar   +1 more source

International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2023
Takao Ohtsuka, C. Fernández‐del Castillo, Toru Furukawa, S. Hijioka, J. Jang, A. Lennon, Yoshihiro Miyasaka, Eizaburo Ohno, R. Salvia, C. L. Wolfgang, Laura D. Wood   +10 more
semanticscholar   +1 more source